BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23469942)

  • 1. Intraperitoneal injection is not always a suitable alternative to intravenous injection for radiotherapy.
    Dou S; Smith M; Wang Y; Rusckowski M; Liu G
    Cancer Biother Radiopharm; 2013 May; 28(4):335-42. PubMed ID: 23469942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor pretargeting in mice using MORF conjugated CC49 antibody and radiolabeled complimentary cMORF effector.
    Liu G; Dou S; Pretorius PH; Liu X; Chen L; Rusckowski M; Hnatowich DJ
    Q J Nucl Med Mol Imaging; 2010 Jun; 54(3):333-40. PubMed ID: 20639818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy.
    Liu G; Dou S; Liu Y; Wang Y; Rusckowski M; Hnatowich DJ
    Bioconjug Chem; 2011 Dec; 22(12):2539-45. PubMed ID: 21985267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preclinical 188Re tumor therapeutic investigation using MORF/cMORF pretargeting and an antiTAG-72 antibody CC49.
    Liu G; Dou S; Baker S; Akalin A; Cheng D; Chen L; Rusckowski M; Hnatowich DJ
    Cancer Biol Ther; 2010 Oct; 10(8):767-74. PubMed ID: 21099368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further investigations of morpholino pretargeting in mice--establishing quantitative relations in tumor.
    Liu G; He J; Dou S; Gupta S; Rusckowski M; Hnatowich DJ
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1115-23. PubMed ID: 16133391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the biodistribution of radiolabeled cMORF effector in MORF-pretargeted mice.
    Liu G; Dou S; He J; Liu X; Rusckowski M; Hnatowich DJ
    Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):237-46. PubMed ID: 17021815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretargeting in tumored mice with radiolabeled morpholino oligomer showing low kidney uptake.
    Liu G; He J; Dou S; Gupta S; Vanderheyden JL; Rusckowski M; Hnatowich DJ
    Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):417-24. PubMed ID: 14691611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (99m)Tc-labeled murine ior C5 monoclonal antibody in colorectal carcinoma patients: pharmacokinetics, biodistribution, absorbed radiation doses to normal organs and tissues and tumor localization.
    Iznaga-Escobar N; Ramos-Suzarte M; Morales-Morales A; Torres-Arocha L; Rodríguez-Mesa N; Pérez-Rodriguez R
    Methods Find Exp Clin Pharmacol; 2004 Nov; 26(9):687-96. PubMed ID: 15632954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replacing 99mTc with 111In improves MORF/cMORF pretargeting by reducing intestinal accumulation.
    Liu G; Cheng D; Dou S; Chen X; Liang M; Pretorius PH; Rusckowski M; Hnatowich DJ
    Mol Imaging Biol; 2009; 11(5):303-7. PubMed ID: 19326173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between two labeled agents in mice using a coinjection-ratio approach in contrast to a conventional group approach.
    Dou S; Wang Y; Barton B; Chen L; Rusckowski M; Shultz LD; Greiner DL; Liu G
    Nucl Med Biol; 2014 Jan; 41(1):127-31. PubMed ID: 24210286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification targeting: a modified pretargeting approach with potential for signal amplification-proof of a concept.
    He J; Liu G; Gupta S; Zhang Y; Rusckowski M; Hnatowich DJ
    J Nucl Med; 2004 Jun; 45(6):1087-95. PubMed ID: 15181145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretargeting CWR22 prostate tumor in mice with MORF-B72.3 antibody and radiolabeled cMORF.
    Liu G; Dou S; Pretorius PH; Liu X; Rusckowski M; Hnatowich DJ
    Eur J Nucl Med Mol Imaging; 2008 Feb; 35(2):272-80. PubMed ID: 17909792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor pretargeting in mice using (99m)Tc-labeled morpholino, a DNA analog.
    Liu G; Mang'era K; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
    J Nucl Med; 2002 Mar; 43(3):384-91. PubMed ID: 11884499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations of 99mTc morpholino pretargeting in mice.
    Liu G; Liu C; Zhang S; He J; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
    Nucl Med Commun; 2003 Jun; 24(6):697-705. PubMed ID: 12766607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro characterization of a dendrimer-MORF conjugate for amplification pretargeting.
    Chen X; Dou S; Liu G; Liu X; Wang Y; Chen L; Rusckowski M; Hnatowich DJ
    Bioconjug Chem; 2008 Aug; 19(8):1518-25. PubMed ID: 18646837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding a clearing agent to pretargeting does not lower the tumor accumulation of the effector as predicted.
    Liu G; Dou S; Chen X; Chen L; Liu X; Rusckowski M; Hnatowich DJ
    Cancer Biother Radiopharm; 2010 Dec; 25(6):757-62. PubMed ID: 21204772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intravenous and intraperitoneal [123I]IBZM injection for dopamine D2 receptor imaging in mice.
    Meyer PT; Salber D; Schiefer J; Cremer M; Schaefer WM; Kosinski CM; Langen KJ
    Nucl Med Biol; 2008 Jul; 35(5):543-8. PubMed ID: 18589298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ratio of maximum percent tumour accumulations of the pretargeting agent and the radiolabelled effector is independent of tumour size.
    Liu G; Dou S; Liang M; Chen X; Rusckowski M; Hnatowich DJ
    Eur J Cancer; 2009 Nov; 45(17):3098-103. PubMed ID: 19811906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment Efficacy.
    Song YS; Paeng JC; Kim HC; Chung JW; Cheon GJ; Chung JK; Lee DS; Kang KW
    Medicine (Baltimore); 2015 Jun; 94(23):e945. PubMed ID: 26061323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF.
    He J; Wang Y; Dou S; Liu X; Zhang S; Liu G; Hnatowich D
    Mol Pharm; 2010 Aug; 7(4):1118-24. PubMed ID: 20507096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.